Gingival fibroblasts as a promising source of induced pluripotent stem cells

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-12

  Egusa, Hiroshi ^a   Okita, Keisuke ^b   Kayashima, Hiroki ^a   Yu, Guannan ^a   Fukuyasu, Sho ^a   Saeki, Makio ^a   Matsumoto, Takuya ^a   Yamanaka, Shinya ^b   Yatani, Hirofumi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; FIBROBLAST; GINGIVA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN EXPRESSION; TERATOMA; ANIMAL; C57BL MOUSE; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION; GENETICS; METABOLISM;

IPS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION; GINGIVA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, INBRED C57BL; TRANSCRIPTION FACTORS;

EID: 77958592067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012743     Document Type: Article

References (50)

1. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Liu H, Zhu F, Yong J, Zhang P, Hou P, et al. (2008) Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3: 587-590.
3. Shimada H, Nakada A, Hashimoto Y, Shigeno K, Shionoya Y, et al. (2010) Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev 77: 2.
4. Ezashi T, Telugu BP, Alexenko AP, Sachdev S, Sinha S, et al. (2009) Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A 106: 10993-10998.
5. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
6. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
7. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105: 2883-2888.
8. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
9. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, et al. (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264.
10. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, et al. (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702.
11. Stadtfeld M, Brennand K, Hochedlinger K (2008) Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18: 890- 894.
12. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, et al. (2008) A druginducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26: 916-924.
13. Yamanaka S (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460: 49-52.
14. Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, et al. (2010) Oct4 and Klf4 Reprogram Dermal Papilla Cells into Induced Pluripotent Stem Cells. Stem Cells 28: 221-228.
15. Li W, Ding S (2010) Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 31: 36-45.
16. Sciubba JJ, Waterhouse JP, Meyer J (1978) A fine structural comparison of the healing of incisional wounds of mucosa and skin. J Oral Pathol 7: 214-227.
17. Walsh LJ, L'Estrange PR, Seymour GJ (1996) High magnification in situ viewing of wound healing in oral mucosa. Aust Dent J 41: 75-79.
18. Sukotjo C, Lin A, Song K, Ogawa T, Wu B, et al. (2003) Oral fibroblast expression of wound-inducible transcript 3.0 (wit3.0) accelerates the collagen gel contraction in vitro. J Biol Chem 278: 51527-51534.
19. Lin A, Hokugo A, Choi J, Nishimura I (2010) Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure. Am J Pathol 176: 108-121.
20. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, et al. (2001) Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol 144: 229-237.
21. Giannopoulou C, Cimasoni G (1996) Functional characteristics of gingival and periodontal ligament fibroblasts. J Dent Res 75: 895-902.
22. Yamada Y, Ueda M, Hibi H, Baba S (2006) A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: A clinical case report. Int J Periodontics Restorative Dent 26: 363-369.
23. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA (2008) Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061.
24. Ueda M, Yamada Y, Kagami H, Hibi H (2008) Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant Dent 17: 82-90.
25. Yamada Y, Nakamura S, Ito K, Kohgo T, Hibi H, et al. (2008) Injectable tissueengineered bone using autogenous bone marrow-derived stromal cells for maxillary sinus augmentation: clinical application report from a 2-6-year followup. Tissue Eng Part A 14: 1699-1707.
26. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, et al. (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151-159.
27. Zeuschner D, Mildner K, Zaehres H, Scholer HR (2010) Induced Pluripotent Stem Cells at Nanoscale. Stem Cells Dev 19: 615-620.
28. Egusa H, Saeki M, Doi M, Fukuyasu S, Matsumoto T, et al. (2010) A smallmolecule approach to bone regenerative medicine in dentistry. J Oral Biosci 52: 107-118.
29. Zaky SH, Cancedda R (2009) Engineering craniofacial structures: facing the challenge. J Dent Res 88: 1077-1091.
30. Seki T, Yuasa S, Oda M, Egashira T, Yae K, et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7: 11-14.
31. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284.
32. Tamaoki N, Takahashi K, Tanaka T, Ichisaka T, Aoki H, et al. (2010) Dental pulp cells for induced pluripotent stem cell banking. J Dent Res 89: 773-778.
33. Yan X, Qin H, Qu C, Tuan RS, Shi S, et al. (2010) iPS cells reprogrammed from mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 19: 469-480.
34. Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem. In press.
35. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
36. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
37. Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12.
38. Takahashi K, Okita K, Nakagawa M, Yamanaka S (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2: 3081-3089.
39. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135.
40. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
41. Martin-Rivera L, Herrera E, Albar JP, Blasco MA (1998) Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci U S A 95: 10471-10476.
42. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
43. Yamanaka S (2009) A fresh look at iPS cells. Cell 137: 13-17.
44. Nikawa H, Egusa H, Makihira S, Okamoto T, Kurihara H, et al. (2006) An in vitro evaluation of the adhesion of Candida species to oral and lung tissue cells. Mycoses 49: 14-17.
45. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
46. Egusa H, Schweizer FE, Wang CC, Matsuka Y, Nishimura I (2005) Neuronal differentiation of bone marrow-derived stromal stem cells involves suppression of discordant phenotypes through gene silencing. J Biol Chem 280: 23691-23697.
47. Ohnuki M, Takahashi K, Yamanaka S (2009) Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol Chapter 4: Unit 4A 2.
48. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, et al. (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6: 88-95.
49. Egusa H, Iida K, Kobayashi M, Lin TY, Zhu M, et al. (2007) Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells. Tissue Eng 13: 2589-2600.
50. Egusa H, Kaneda Y, Akashi Y, Hamada Y, Matsumoto T, et al. (2009) Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts. Biomaterials 30: 4676-4686.